Dobutamine Impurity 19 | CAS 130783-39-0 - Request Quote
Dobutamine Impurity 19
| SZ CAT No: | SZ-D095027 |
| CAS No | 130783-39-0 |
| Mol.F. | C19H24N2O4 |
| Mol.Wt. | 344.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dobutamine Impurity 19 is chemically 4-(3-((2-(3,4-Dihydroxyphenyl)-2-hydroxyethyl)amino)butyl)benzamide. Dobutamine Impurity 19 is supplied with detailed characterization data compliant with regulatory guideline. Dobutamine Impurity 19 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dobutamine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 130783-39-0
Purchase 130783-39-0
Order 130783-39-0
Enquire 130783-39-0
price of 130783-39-0
130783-39-0 Supplier
130783-39-0 Manufacturer
130783-39-0 Exporter
buy high quality Dobutamine Impurity 19
Purchase Dobutamine Impurity 19
Dobutamine Impurity 19 suppliers
Dobutamine Impurity 19 manufacturers
Dobutamine Impurity 19 price
Order Dobutamine Impurity 19
Enquire Dobutamine Impurity 19
Dobutamine Impurity 19 cost
Dobutamine Impurity 19 Supplier
Dobutamine Impurity 19 Distributor
Dobutamine Impurity 19 for Method Validation
Dobutamine Reference Standard
Dobutamine Impurity 19 for ANDA Filing
Dobutamine Impurity 19 for Forced Degradation Studies
Dobutamine Impurity 19 Identification Standards
Dobutamine Impurity 19 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


